Skip to main content

Specificity and Modulation of the Eosinophil Polymorphonuclear Leukocyte Response to the Eosinophil Chemotactic Factor of Anaphylaxis (ECF-A)

  • Chapter
Molecular and Biological Aspects of the Acute Allergic Reaction

Abstract

After their generation from myeloid precursors in bone marrow, eosinophil polymorphonuclear (PMN) leukocytes circulate for a brief period in peripheral blood and then emigrate to tissue pools localized predominantly in the lungs, skin, intestines and genitourinary tract (Hudson, 1968; Spry, 1971; Zucker-Franklin, 1974). An increase in the level of eosinophils in peripheral blood and in involved tissues is a prominent feature of systemic immediate hypersensitivity reactions (Campbell et al, 1935). The selective influx of eosinophils to the focus of an immediate hypersensitivity reaction is governed by the tissue levels of diverse eosinophil chemotactic factors, by the biodegradation or inhibition of the chemotactic factors, and by reversible and irreversible alterations in the chemotactic responsiveness of the target cells (Goetzl et al, 1975). The net effect of this series of interactions is the positioning of a critical number of eosinophils at the site of an immediate hypersensitivity reaction so that they may exercise their specific regulatory role (Goetzl et al, 1975).

supported by grants AI-07722 and AI-10356 from the National Institutes of Health.

Investigator, Howard Hughes Medical Institute.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Archer, R.K. 1956. The eosinophilic response in the horse to intramedullary and intradermal injections of histamine, ACTH, and cortisone. J. Pathol. Bact. 72:87.

    Article  CAS  Google Scholar 

  • Berenberg, J.A., and Ward, P.A. 1973. Chemotactic factor inactivator in normal human serum. J. Clin. Invest. 52:1200.

    Article  PubMed  CAS  Google Scholar 

  • Bokisch, V.A., and Müller-Eberhard, H.J. 1970. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49:2427

    Article  PubMed  CAS  Google Scholar 

  • Campbell, A.C.P., Drennan, A.M., and Rettie, R. 1935. The relationship of the eosinophile leukocyte to allergy and anaphylaxis. J. Path. Bact. 40:537.

    Article  CAS  Google Scholar 

  • Clark, R.A.F., Gallin, J.I., and Kaplan, A.P. 1975. The selective eosinophil chemotactic activity of histamine. J. Exp. Med. 142:1462.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J. 1975. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann. N.Y. Acad. Sci. 256:210.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J., and Austen, K.F. 1972. A neutrophil immobilizing factor derived from human leukocytes. I, Generation and partial characterization. J. Exp. Med. 136:1564.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J., and Austen, K.F. 1974. Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J. Clin. Invest. 53:591.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J., and Austen, K.F. 1975. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. USA 72:4123.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J., Gigli, I., Wasserman, S.I., and Austen, K.F. 1973. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J. Immunol. 111:938.

    PubMed  CAS  Google Scholar 

  • Goetzl, E.J., Wasserman, S.I., Gigli, I., and Austen, K.F. 1974a. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. Clin. Invest. 53:813.

    Article  PubMed  CAS  Google Scholar 

  • Goetzl, E.J., Wasserman, S.I., and Austen, K.F. 1974b. Modulation of the eosinophil chemotactic response in immediate hypersensitivity. In: Progress In Immunology II, L. Brent and J. Holborow, eds., vol. 4, North-Holland Publishing Co., Amsterdam, p. 41.

    Google Scholar 

  • Goetzl, E.J., Wasserman, S.I., and Austen, K.F. 1975. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch. Pathol. 99:1.

    PubMed  CAS  Google Scholar 

  • Goetzl, E.J., Boswell, R.N., and Austen, K.F. 1976a. The tetrapeptides comprising eosinophil chemotactic factor of anaphylaxis (ECF-A): Structural determinants of chemotactic activity. Fed. Proc. (abstract), in press.

    Google Scholar 

  • Goetzl, E.J., Rubin, R.H., McDonough, J., Tashjian, A.H., Jr., Austen, K.F. 1976b. Production of eosinophilotactic peptides by bronchogenic carcinoma jin situ and in vitro. Clin. Res. (abstract), in press.

    Google Scholar 

  • Hudson, G. 1968. Quantitative study of the eosinophil granulocytes. Semin. Hematol. 5:166.

    PubMed  CAS  Google Scholar 

  • Kaliner, M.A., Wasserman, S.I., and Austen, K.F. 1973. The immunologic release of chemical mediators from human nasal polyps. N. Engl. J. Med. 289:277.

    Article  PubMed  CAS  Google Scholar 

  • Kay, A.B., and Austen, K.F. 1971. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J. Immunol. 107:899.

    PubMed  CAS  Google Scholar 

  • Kay, A.B., Shin, H.S., and Austen, K.F. 1973. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology 24:969.

    PubMed  CAS  Google Scholar 

  • Kay, A.B., Stechschulte, D.J., and Austen, K.F. 1971. An eosinophil leukocyte chemotactic factor of anaphylaxis. J. Exp. Med. 133:602.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, R.A., Goetzl, E.J., Wasserman, S.I., Valone, F.H., Rubin, R.H., and Austen, K.F.: The release of four mediators of immediate hypersensitivity from human leukemic basophils. J. Immunol. 114:87.

    Google Scholar 

  • McKenzie, R., Pepper, D.S., and Kay, A.B. 1975. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen. Thrombosis Res. 6:1.

    Article  CAS  Google Scholar 

  • Najjar, V.A. 1974. The physiological role of γ-globulin. Advan. Enzymol. 41:129.

    CAS  Google Scholar 

  • Nishioka, K., Constantopoulos, A., Satoh, P.S., and Najjar, V.A. 1972. The characteristics, isolation and synthesis of the phagocytosis stimulating peptide Tuftsin. Biochem. Biophys. Res. Commun. 47:172.

    Article  PubMed  CAS  Google Scholar 

  • Parish, W.E. 1970. Investigations on eosinophilia. The influence of histamine, antigen-antibody complexes containing γl or γ2 globulins, foreign bodies (phagocytosis) and disrupted mast cells. Brit. J. Dermatol. 82:42.

    Article  CAS  Google Scholar 

  • Snyderman, R., Shin, H.S., and Hausman, M.H. 1971. A chemotactic factor for mononuclear leukocytes. Proc. Soc. Exp. Biol. Med. 138:387.

    PubMed  CAS  Google Scholar 

  • Spry, C.J.F. 1971. Mechanism of eosinophilia: V. Kinetics of normal and accelerated eosinopoiesis. Cell Tissue Kinet. 4:351.

    PubMed  CAS  Google Scholar 

  • Torisu, M., Yoshida, T., Ward, P.A., and Cohen, S. 1973. Lymphocyte-derived eosinophil chemotactic factor: II. Studies on the mechanism of activation of the precursor substance by immune complexes. J. Immunol. 111:1450.

    PubMed  CAS  Google Scholar 

  • Turner, S.R., Campbell, J.A., and Lynn, W.S. 1975. Polymorphonuclear leukocyte Chemotaxis toward oxidized lipid components of cell membranes. J. Exp. Med. 141:1437.

    Article  PubMed  CAS  Google Scholar 

  • Vallota, E.H., and Müller-Eberhard, H.J. 1973. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J. Exp. Med. 137:1109.

    Article  PubMed  CAS  Google Scholar 

  • Vaughn, J. 1953. The function of the eosinophile leukocyte. Blood 8:1.

    PubMed  CAS  Google Scholar 

  • Vegad, J.L. and Lancaster, M.C. 1972. Eosinophil leukocyteattracting effect of histamine in the sheep skin. Indian J. Exp. Biol. 10:147.

    CAS  Google Scholar 

  • Ward, P.A. 1967. A plasmin-split fragment of C3 as a new chemotactic factor. J. Exp. Med. 126:189.

    Article  PubMed  CAS  Google Scholar 

  • Ward, P.A. 1971. Complement-derived leukotactic factors in pathological fluids. J. Exp. Med. 134:1095.

    Article  Google Scholar 

  • Ward, P.A., and Becker, E.L. 1968. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. Exp. Med. 127:693.

    Article  PubMed  CAS  Google Scholar 

  • Ward, P.A., and Becker, E.L. 1970. Biochemical demonstration of the activatable esterase of the rabbit neutrophil involved in the chemotactic response. J. Immunol. 105:1057.

    PubMed  CAS  Google Scholar 

  • Ward, P.A., and Hill, J.H. 1970. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104:535.

    PubMed  CAS  Google Scholar 

  • Wasserman, S.I., Goetzl, E.J., Kaliner, M.A., and Austen, K.F. 1974a. Modulation of the immunologic release of the eosinophil chemotactic factor of anaphylaxis from human lung. Immunology 26:677.

    PubMed  CAS  Google Scholar 

  • Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1974b. Preformed eosinophil chemotactic factor of anaphylaxis. J. Immunol. 112:351.

    PubMed  CAS  Google Scholar 

  • Wasserman, S.I., Goetzl, E.J., Ellman, L., and Austen, K.F. 1974c. Tumor-associated eosinophilotactic factor. N. Engl. J. Med. 290:420.

    Article  PubMed  CAS  Google Scholar 

  • Wasserman, S.I., Whitmer, D., Goetzl, E.J., and Austen, K.F. 1975. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis. Proc. Soc. Exp. Biol. Med. 148:301.

    PubMed  CAS  Google Scholar 

  • Wasserman, S.I., Boswell, R.N., Drazen, J.M., Goetzl, E.J., and Austen, K.F. 1976. Functional specificity of the human lung acidic tetrapeptides constituting eosinophil chemotactic factor of anaphylaxis (ECF-A). J. Allergy Clin. Immunol., in press.

    Google Scholar 

  • Zucker-Franklin, D. 1974. Eosinophil function and disorders. Adv. Intern. Med. 19:1.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Goetzl, E.J., Austen, K.F. (1976). Specificity and Modulation of the Eosinophil Polymorphonuclear Leukocyte Response to the Eosinophil Chemotactic Factor of Anaphylaxis (ECF-A). In: Johansson, S.G.O., Strandberg, K., Uvnäs, B. (eds) Molecular and Biological Aspects of the Acute Allergic Reaction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4304-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4304-2_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4306-6

  • Online ISBN: 978-1-4613-4304-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics